GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

COMPARED to most head and neck malignancies, the rate of throat cancer in the United States and around the globe has not declined. The statistics are also true, when extrapolated, for other countries, ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

Ever since recombinant DNA has been used to develop and manufacture vaccines, antivaxxers have portrayed it as evil. This ...

We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Cervical cancer, a key cause of cancer-related deaths among Indian women, can be prevented and cured through early screening ...

We recently published a list of 10 Most Promising Low-Cost Stocks According to Hedge Funds. In this article, we are going to ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...

新泽西州拉威市 - 默沙东集团（NYSE: MRK）宣布其21价肺炎球菌结合疫苗CAPVAXIVE在IDWeek 2024上公布的STRIDE-8三期临床试验结果积极。该研究将CAPVAXIVE与现有疫苗进行比较，结果显示它对所有21种血清型都具有免疫原性，并在慢性病成年人中表现出良好的安全性。 根据疾控中心2018-2021年的数据，CAPVAXIVE针对的血清型约占50岁及以上成年人侵袭性肺炎 ...

Future of Healthcategory Musk's Neuralink says tiny wires of brain chip in first patient now stable July 11, 2024 Future of Healthcategory US FDA approves expanded use of Sarepta's Duchenne gene ...